Paul M. Sondel
Affiliations: | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, Immunology, Microbiology BiologyGoogle:
"Paul Sondel"Children
Sign in to add trainee| Hillary D. Lum | grad student | 2006 | UW Madison |
| Brenda L. Soto | grad student | 2010 | UW Madison |
| Richard Yang | grad student | 2012 | UW Madison |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jin WJ, Jagodinsky JC, Vera JM, et al. (2023) NK cells propagate T cell immunity following in situ tumor vaccination. Cell Reports. 42: 113556 |
| Li Z, Ding Y, Liu J, et al. (2022) Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment. Nature Communications. 13: 1845 |
| Bates PD, Rakhmilevich AL, Cho MM, et al. (2021) Combining Immunocytokine and Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2 Murine Neuroblastoma. Frontiers in Immunology. 12: 668307 |
| Patel RB, Hernandez R, Carlson P, et al. (2021) Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13 |
| Pieper AA, Rakhmilevich AL, Spiegelman DV, et al. (2021) Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice. Journal For Immunotherapy of Cancer. 9 |
| Baniel CC, Sumiec EG, Hank JA, et al. (2020) Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model. Journal For Immunotherapy of Cancer. 8 |
| Baniel CC, Heinze CM, Hoefges A, et al. (2020) Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Frontiers in Immunology. 11: 1610 |
| Bishop MW, Hutson PR, Hank JA, et al. (2020) A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors. Mabs. 12: 1773751 |
| Damodharan SN, Walker KL, Forsberg MH, et al. (2020) Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation. Cytotherapy |
| Goldberg JL, Navid F, Hank JA, et al. (2020) Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma. Journal For Immunotherapy of Cancer. 8 |